Apply immediately after cleansing in the a.m. and p.m. daily. Follow with moisturizer, in addition to SPF protection after morning application.
Undecylenoyl Phenylalanine [UDP]: Works effectively to interfere with the emergence of visible age spots and localized pigmentation. [Trade name: Sepiwhite]
Manganese Tripeptide-1 Complex: A non-toxic inhibitor of melanin promotes even skin tone.
Glycyrrhiza Glabra [Licorice] Root Extract: Inhibits tyrosinase activity and provides effective soothing.
Ascorbyl Palmitate: A form of Vitamin C, scavenges free radicals, stabilizes oxygen-sensitive molecules and skillfully brightens.
Clinical Study: Overall Dermatologist Assessment: After three months of treatment, 93% of the volunteers found the formula to be safe, effective and comfortable. In addition, tolerance was excellent on all the persons tested.
Water (Aqua), Caprylic/Capric Triglyceride, Hydrogenated Polyisobutene, Glycerin, Propylene Glycol, Undecylenoyl Phenylalanine, Arachidyl Alcohol, Glyceryl Stearate, Cetyl Alcohol, Behenyl Alcohol, Cyclopentasiloxane, PEG-100 Stearate, Stearyl Alcohol, Glycyrrhiza Glabra (Licorice) Root Extract, Sodium Hyaluronate, Manganese Tripeptide-1, Polyacrylate-13, Phenoxyethanol, Arachidyl Glucoside, Hydrogenated Polyisobutene, Ascorbyl Palmitate, DIMETHICONE, Polyisobutene, Xanthan Gum, Sodium Hydroxide, Sodium Lactate, Polysorbate 20, Ethylhexylglycerin, Butylene Glycol, Citric Acid.
For all skin types, even the most sensitive exhibiting at-rest wrinkling, distinctive pigment changes, prominent discolorations, small but noticeable blood vessels and/or visible keratoses.
WHAT IT’S FORMULATED TO DO
Clinical Evaluation of U.Phenylalanine – Results in just 8 weeks:
- Decreased surface melanin pigmentation, resulting in visible clarity.
- Evened skin tone significantly for overall correcting.
- Lightened and visibly corrected discolorations and hyperpigmentation, while interfering with the production of future dark spots.
Medium to thick cosistency serum absorbs quickly.
There are no reviews yet.